Financial Wire

CIBCはアライド・プロパティーズREITの投資判断を「中立」に据え置き、目標株価を11ドルに引き上げた。

-- CIBCキャピタル・マーケッツは、アライド・プロパティーズ・リアル・エステート・インベストメント・トラスト(AP-UN.TO)の投資信託(ユニット)に対する投資判断を「中立」に据え置き、目標株価を10.50ドルから11.00ドルに引き上げた。 同行は、同社の投資信託がここ数週間で市場を「大幅に上回るパフォーマンス」を示していると指摘した。目標株価11.00ドルは、2027年FFO/ユニット予想の10.6倍に基づいており、これは修正後の純資産価値予想に対して1%のプレミアムとなる。 アナリストのタル・ウーリー氏は、「経営陣と取締役会の交代により、APのリース戦略に変化が生じ始めており、これが3年間の業績見通しの達成に貢献すると期待している」と述べた。「いくつかの投機的な要因により、投資信託のユニット価格は今後も上昇を続ける可能性があるが、事業の回復には数年かかる見込みであり、これはAPが第4四半期決算発表と5億6000万ドルの株式発行後に示した内容と一致する」と付け加えた。 CIBCは、市場が「より迅速なファンダメンタルズ回復を期待しているか、あるいは何らかの投機的な要因が働いている可能性がある」と考えている。 「第3四半期(2025年)の決算発表で株価が急騰した後、17%下落したことを踏まえ、AP株を積極的に買い求めることには慎重を期すべきだ。2026年後半まで、APの業績が明確に好転するとは予想していない」とウーリー氏は付け加えた。「これはAPの3年間の見通しと一致する。APの財務回復には時間がかかるだろう。」 同行はまた、経営陣向け通達において、取締役会が役員報酬の裁量的な減額調整を行ったことを指摘した。さらに、再編成された経営陣は、より柔軟なリース戦略によって「より大きな成功を収める」と見込んでいる。 (は、北米、アジア、ヨーロッパの主要銀行および調査会社による株式、商品、経済に関する調査レポートを配信しています。調査レポート提供者の方は、こちらからお問い合わせください:https://www..com/contact-us

Price: $11.27, Change: $+0.59, Percent Change: +5.52%

Related Articles

Australia

Sector Update: Financial Stocks Softer Late Afternoon

Financial stocks fell in late Thursday afternoon trading with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.2%.The Philadelphia Housing Index dropped 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) rose 0.8%.Bitcoin (BTC-USD) gained 0.4% to $75,140, and the yield for 10-year US Treasuries advanced 2.7 basis points to 4.309%.In economic news, US initial jobless claims last week fell to 207,000 from a downwardly revised 218,000 in the previous week, compared with expectations for a smaller decrease to 213,000 in a survey of analysts by Bloomberg.US industrial production fell by 0.5% in March, compared with expectations for a 0.1% increase in a Bloomberg survey, and following an upwardly revised 0.7% increase in February.The Philadelphia Federal Reserve's monthly manufacturing index rose to 26.7 in April after increasing to 18.1 in March, compared with expectations for a decline to 10 in a survey compiled by Bloomberg.The New York Federal Reserve's services index improved to minus 14 in April from minus 22.6 in March, compared with minus 20 expected in a survey compiled by Bloomberg.In regulatory news, the US Securities and Exchange Commission is seeking public comment in support of a comprehensive review of the Consolidated Audit Trail and other such audit trails used in the regulation of the country's securities markets.In corporate news, Charles Schwab's (SCHW) Q1 results rose amid a surge in client assets, even as revenue fell short of Wall Street's estimates. The shares fell 7.7%.Goldman Sachs (GS) rates-trading business faced pressure in Q1 as Iran-related market volatility led to losses on certain positions, Reuters reported. The bank posted a 10% drop in fixed-income, currencies and commodities revenue to $4 billion, driven by weaker results in interest-rate trading, mortgages, and credit products, the report said. Goldman shares were little changed.Marsh & McLennan (MRSH) shares climbed 4.6% after the company reported Q1 adjusted net income and revenue that surpassed analysts' estimates.The National Basketball Association is in early discussions with private credit firms, including Apollo Global Management (APO), Ares Management (ARES) and Sixth Street about funding a potential European basketball league expansion, Bloomberg reported. Apollo shares rose 0.1%, and Ares fell 2.7%.

$APO$ARES$GS$MRSH$SCHW
Japan

US Equity Indexes Advance After Trump Announces Israel-Lebanon Ceasefire Deal

US equity indexes rose ahead of Thursday's close after Israel and Lebanon agreed to a 10-day ceasefire, removing a major obstacle to the Middle East diplomacy for a lasting Iran truce deal.The Nasdaq Composite rose 0.2% to 24,069.1, with the S&P 500 up 0.2% to 7,035.2, and the Dow Jones Industrial Average higher by 0.2% to 48,583.5. Energy, real estate, and technology led the gainers. Health care was the worst performer.President Trump said the US might hold discussions with Iran this weekend, The Wall Street Journal reported. "We're very close to making a deal," the president told reporters outside the White House, according to the WSJ. Trump said he wasn't sure the current two-week ceasefire in the war would need to be extended, according to the report.Earlier on Thursday, Trump said on Truth Social that Lebanon and Israel have agreed to a 10-day ceasefire starting 5 pm ET. Lebanese Prime Minister Nawaf Salam said he welcomed the decision. In a follow-up social media post on Thursday, Trump said he will invite the Lebanese President, Joseph Aoun, and Israel's Prime Minister Benjamin Netanyahu to the White House for talks.Meanwhile, US Defense Secretary Pete Hegseth said Thursday that the naval blockade of Iran is an example of "polite" behavior during the ongoing ceasefire, and US forces are ready to strike power plants and the energy industry in the country, if ordered, according to a report from Reuters.West Texas Intermediate crude oil futures rose 2.5% to $93.77, and Brent crude futures jumped 3.7% to $98.58.

$^DJI$^IXIC$^SPX
Sectors

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.7%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 5%.Gilead Sciences (GILD) could beat Q1 consensus estimates, but weaker-than-expected persistence rates for Yeztugo point to a potential risk to long-term peak sales for the HIV pre-exposure prophylaxis drug, RBC Capital Markets said in a note. Gilead shares were down 0.8%.QuidelOrtho (QDEL) shares tumbled 28%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares jumped past 12% after a senior US health official signaled plans to ease restrictions on certain peptides.

$ABT$GILD$HIMS$QDEL